Celanese (NYSE: CE) director receives phantom stock compensation award

Rhea-AI Filing Summary

Celanese Corp director Jay V. Ihlenfeld received a small phantom stock award as part of deferred compensation. On this date, he acquired 6.0600 phantom stock units, each representing the right to receive one share of Celanese common stock. These units reflect dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan and will be paid in common shares according to that plan’s terms. Following this grant, Ihlenfeld directly holds a total of 10241.1190 phantom stock units linked to Celanese common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider IHLENFELD JAY V

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock	6.06	$50.67	$307.06

Holdings After Transaction: Phantom Stock — 10,241.119 shares (Direct)

Footnotes (1)

1. Each share of phantom stock represents the right to receive one share of Common Stock. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

IHLENFELD JAY V

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W. LAS COLINAS BLVD., SUITE 900N

(Street)

IRVING TX 75039-5421

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	03/10/2026		A		6.06		(2)	(2)	Common Stock	6.06	$50.67	10,241.119	D

Explanation of Responses:

1. Each share of phantom stock represents the right to receive one share of Common Stock.

2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Jay V. Ihlenfeld	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese (CE) report for Jay V. Ihlenfeld?

Celanese reported that director Jay V. Ihlenfeld acquired 6.0600 phantom stock units. These units are part of his deferred compensation and mirror dividend equivalents, to be settled in Celanese common stock under the company’s 2008 Deferred Compensation Plan.

How many phantom stock units does the Celanese (CE) director hold after this Form 4?

After this transaction, Jay V. Ihlenfeld holds 10241.1190 phantom stock units directly. Each unit represents the right to receive one share of Celanese common stock, payable in shares according to the company’s 2008 Deferred Compensation Plan.

Is the Celanese (CE) Form 4 transaction an open-market buy or sell?

The Form 4 does not show an open-market buy or sell. It records a grant-type acquisition of 6.0600 phantom stock units as dividend-equivalent compensation under Celanese’s 2008 Deferred Compensation Plan, not a purchase or sale on the stock market.

What is phantom stock in the Celanese (CE) director’s Form 4 filing?

In this filing, each share of phantom stock represents the right to receive one share of Celanese common stock. These phantom shares arise from dividend equivalents on deferred compensation and are payable in common stock as outlined in the company’s 2008 Deferred Compensation Plan.

Why did Celanese (CE) credit dividend equivalents as phantom stock to its director?

Celanese credited 6.0600 phantom stock units as dividend equivalents on compensation deferred under its 2008 Deferred Compensation Plan. This structure lets deferred amounts mirror dividends as if invested in Celanese stock, later settled in actual shares under the plan’s terms.